GlassScriptPhysician profile
Donna P Evans
NPI 1942317037
$1,337.76
in general payments reported to CMS, 2019-2025
12 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $158 · 2023: $141 · 2024: $651 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $262.14 | 2023-2024 | Farxiga, Lokelma |
| Calliditas Therapeutics US INC. | $236.83 | 2024-2025 | Tarpeyo |
| Vifor Pharma, INC. | $207.37 | 2022-2024 | Veltassa |
| Travere Therapeutics, INC. | $146.93 | 2025 | Filspari |
| Glaxosmithkline, LLC. | $122.76 | 2024 | Benlysta |
| Bayer Healthcare Pharmaceuticals INC. | $101.41 | 2024 | |
| Fresenius USA Marketing, INC. | $86.69 | 2022-2024 | Liberty Select Cycler, Nxstage System One |
| Novo Nordisk INC | $82.21 | 2025 | Ozempic |
| Otsuka America Pharmaceutical, INC. | $34.82 | 2024-2025 | Jynarque |
| Aurinia Pharma U.S., INC. | $22.13 | 2022 | |
| Ardelyx, INC. | $17.40 | 2025 | Ibsrela |
| Axsome Therapeutics, INC. | $17.07 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.